Amit Maity Selected Research

Growth Differentiation Factor 15

1/2019

Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amit Maity Research Topics

Disease

44	Neoplasms (Cancer) 11/2023 - 11/2004
16	Hypoxia (Hypoxemia) 01/2022 - 11/2004
8	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2003
6	Lymphoma (Lymphomas) 01/2023 - 01/2019
5	Melanoma (Melanoma, Malignant) 01/2022 - 04/2015
5	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2016
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 02/2007
4	Brain Neoplasms (Brain Tumor) 07/2019 - 11/2006
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2008
3	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2019
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2023 - 01/2021
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2022 - 10/2021
2	Colitis 01/2022 - 01/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 01/2020
2	AIDS-Related Complex (ARC) 01/2020 - 09/2015
2	Glioma (Gliomas) 01/2018 - 02/2011
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2018 - 12/2012
2	Carcinoma (Carcinomatosis) 12/2012 - 02/2007
1	Parkinson Disease (Parkinson's Disease) 11/2023
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023
1	Primary Myelofibrosis (Myelosclerosis) 01/2022
1	Radiation Injuries (Radiation Sickness) 01/2022
1	Multiple Myeloma 12/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Inflammatory Breast Neoplasms 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Dyspnea (Shortness of Breath) 01/2021
1	Fatigue 01/2021
1	Hematologic Diseases (Blood Diseases) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Leukemia 01/2020
1	Disseminated Intravascular Coagulation 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019
1	Genomic Instability 01/2018

Drug/Important Bio-Agent (IBA)

13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2011 - 01/2003
7	Nelfinavir (Viracept)FDA Link 01/2021 - 09/2006
6	ErbB Receptors (EGF Receptor)IBA 07/2010 - 01/2003
5	Protons (Proton)IBA 01/2023 - 01/2019
5	Oxygen (Dioxygen)IBA 01/2022 - 05/2005
5	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2016
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 07/2006
4	TensinsIBA 01/2020 - 07/2006
4	Messenger RNA (mRNA)IBA 02/2011 - 01/2003
3	Chimeric Antigen ReceptorsIBA 03/2023 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2006
3	HIV Protease InhibitorsIBA 10/2019 - 09/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 12/2012
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2014 - 11/2006
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2011 - 09/2006
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2010 - 03/2006
2	Rituximab (Mabthera)FDA Link 01/2023 - 01/2021
2	IpilimumabIBA 01/2022 - 01/2021
2	SteroidsIBA 01/2022 - 01/2021
2	Prednisone (Sone)FDA LinkGeneric 01/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 10/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 08/2009
2	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2018 - 12/2012
2	DNA-Activated Protein KinaseIBA 01/2018 - 12/2012
2	RNA (Ribonucleic Acid)IBA 09/2017 - 02/2011
2	Temozolomide (Temodar)FDA LinkGeneric 01/2014 - 05/2007
2	dactolisibIBA 12/2012 - 09/2012
2	TOR Serine-Threonine KinasesIBA 01/2011 - 07/2006
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2009 - 01/2003
2	Small Interfering RNA (siRNA)IBA 07/2006 - 11/2004
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2023
1	Busulfan (Busulfex)FDA Link 01/2022
1	fludarabineIBA 01/2022
1	GlucocorticoidsIBA 01/2022
1	B-Cell Maturation AntigenIBA 12/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2021
1	Aligeron (AS 2)IBA 01/2021
1	Human immunodeficiency virus 1 p16 proteaseIBA 01/2021
1	Brentuximab VedotinIBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	axicabtagene ciloleucelIBA 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 01/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	tisagenlecleucelIBA 01/2020
1	Epirubicin (Ellence)FDA LinkGeneric 01/2020
1	fibrin fragment D (D-dimer)IBA 01/2020
1	MicellesIBA 01/2020
1	Growth Differentiation Factor 15IBA 01/2019
1	pembrolizumabIBA 11/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Placental ExtractsIBA 10/2017

Therapy/Procedure

32	Radiotherapy 08/2023 - 04/2003
25	Therapeutics 03/2023 - 11/2006
10	Drug Therapy (Chemotherapy) 01/2023 - 11/2006
5	Immunotherapy 11/2023 - 11/2015
3	Proton Therapy 01/2021 - 09/2015
2	Chemoradiotherapy 10/2019 - 01/2014
1	Combined Modality Therapy 01/2023
1	Cell Transplantation 01/2022